Member Info for elrico

Farris,

Yes I did. And yes I did.

It will be a written Q&A not audio because I looked like death warms up yesterday, and sounded awful. Covid for the fourth time. Biden is a liar!!!

I will try my best to publish before we sit for Christmas lunch. A lot covered, and a lot to be excited about, IMHO.

That was the answer. The board are restricted.

Just a guess, but I’d imagine because of the M&A activity that looks likely to be concluded in early 2023, if I’m reading the tea leaves correct. :)

Love a bit of Pink Floyd.

I asked.

I believe it’s the max allowed.

Yes, DC. That is my understanding.

Clio, et al.

Working on it.

That is precisely the plan, you see this, right? It is strategically brilliant if it is pulled off. Ready-made brands, with proven sales, in both pharmacy and the NHS. Give the board some credit for once.

OK, how about this...

Perhaps the acquisition is all but done? Ah, but it can't be because they would need to announce it! What if the target party inserts a clause...I don't know, say, show us you have the funds, and we then we can sign it off.

IMHO, the acquisition is all but done and will be completed in January. The only issue I see is the unlikely take up of the PI open offer unless there is a collective light bulb moment!

Aqua,

It is exceptionally rare for investors to vote against a board in such circumstances. It is clear to me they have the votes with the boards holding, OPTI, and the main institutions. The clue is the £2.5m is a done deal at an agreed 16p, which is great news in today's market.

The board are also taking part. I hope they are opting to mop up the open offer. lol

OMG, £2.5m done. Open offer at 16p is not. Come on Bel, you're smarter than this. There are what I believe to be significant clues in the RNS and you claim the best bit is about the Post initial launch of the AxisBiotix-Ps™ product! Wow!

Is nobody putting the puzzle together?

TraderBuckie

Like me, you are looking at the bigger picture. IMHO this has been in the pipe for some time. SA reaction when I posed the question is, in hindsight, a bad poker tell! :)
38 mins. I also included the link in tonight's update.

https://www.youtube.com/channel/UCypdNlbFNCvwtaPJfpdK7HQ

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-51e?sd=pf

Phat,

You're such an emotional BBM. Is there anything to report on? No! Unless you wish to discuss my experiment with AxisBiotix - there isn't a great deal to discuss unless you want me to whinge and whine about the SP, the £1.2m, and slow AxisBiotix sales, and perhaps you want my opinion on ongoing discussions with the MN(s)!! AGAIN AND AGAIN!!!

Phat, you're a typical AIM BBM, a typical ex-holder. These forums are littered with ex-investors *****ing and baiting investors. They are always by people like you that invest by emotion and wonder why it's everyone's fault but your own!

This is my last word to you. I've three unanswered questions about you misquoting me; Toyin has a couple more. You never answer awkward questions. Instead, you have an emotional outburst, throw a hissy fit and run. So, I will do what some members have asked me to: stop allowing myself to be baited by an emotional ex-investor.

You are now confined to the filter bin!

Not that I recall.
That is not the anticipated observation I was hoping for. :)

I can see the point about BBE date, but we should start with the "assumption" the Company has sensible stock control. The batch No support this assumption. For example, the first recorded batch No I have is 21E0546 (used for the bog-off launch). The batch No has been sequential 21E0875, 0877, the next 0894/98. However, as we can see, there are no 88 batches, which is a lot of stock because each batch is *c6500 boxes. *as far as my old grey can recall.

The current batch I have is 21E0894 BBF 08/23, so there is plenty of time. I have out-of-date Cholx3, which is still working fine. If BBE date gets too close, they will discount as every other retail outfit does. OPTI does this every few months.

For example, if a subscriber has applied a discounted offer, I think it is normal to chuck in a near BBE date and trust the customer to use this first before the other with a longer BBE.

If marketing is reading this, and you have not thought of this, I'll accept a one-year discount; thank you very much. :)

Aqua,

What hair I have remains intact.

You seem to think I was disrespectful to Mol. I’m sorry if my comments came across this way, and hope Mol doesn’t think as you do. Mol is usually balanced and respectful, if not a little cheeky at times. Humour I appreciate.

However, I felt Mols response was a tad overblown. I don’t view my comments as attack on Mol.

Mad articulated the likely situation a new CFOs priority and why he needs to get it right from the getgo. There speaks an account, I’d wager.

I thought it was reasonable to flag more serious issues Mol seems happy to overlook, but, to my mind and more experienced investors here appear to agree the late accounts is not a big issue, especially as we already know what they are.

Mol,

Yet, you say nothing about OPTI presenting at IMC, not answering Qs.
Telling SP they are funded, then raising £500k

which was ****ed up (by Cenkos - apparently).
So are we to believe Cenkos can’t function from a basic template for a fund raise!!!!

Pump?
mislead the market?
And you say nothing, but kick off over an AGM statement and later than normal accounts, even though we know what’s likely to be contained in them!

Take a bow!

Aqua,

There’s not need to apologise, you’re not my wife. :)

Floridajoe
It is rare for an AIM CEO to put investors first ahead of personal gain. Stuart and indeed, Cath have done that. All they ask is trust and patience.

Aqua,

There is new information in there that provides a reasonable timeline for Acne and how this ties in with negotiations with the MN(S). A little more clarity on expectations from the Croda meetings.

If you're in Chester over the next few days...I'll suffer them, for the team, of course! :)

Ordinarily, the costs are governed by the percentage holding. However, salaries should be controlled by a CFO worth their salt. So, for example, CF at hVIVO and POLB split his hours between the two, and his salary package costs are divided, with no double tapping, so to speak.

SOH does not strike me as someone that takes liberties with shareholder cash.